Levoquin 250 mg Cipla

£7.00

Levoquin 250mg is a broad-spectrum fluoroquinolone antibiotic manufactured by Cipla containing levofloxacin for bacterial resistance research and antimicrobial susceptibility studies in laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Levoquin 250 mg Cipla
Levoquin 250 mg Cipla
£7.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications of Levofloxacin

Levoquin 250mg is a broad-spectrum fluoroquinolone antibiotic containing levofloxacin as the active pharmaceutical ingredient. Manufactured by Cipla, this formulation provides researchers with a standardised reference compound for investigating bacterial resistance mechanisms, antimicrobial efficacy, and pharmacological properties in controlled laboratory settings. The fluoroquinolone class represents a critical tool in microbiology research, with levofloxacin serving as an important benchmark for studying DNA gyrase inhibition and topoisomerase IV interactions in bacterial cell cultures.

Research scientists at Stroid UK Shop frequently examine levofloxacin alongside other antimicrobial compounds available in our extensive catalogue, including SARMs and peptides for comparative pharmacokinetic studies. The 250mg dosage strength enables precise analytical work and concentration-response evaluations across various bacterial strains.

Mechanism and Research Properties

Levofloxacin operates through selective inhibition of bacterial DNA gyrase and topoisomerase IV enzymes, disrupting DNA replication and transcription processes. This mechanism makes it particularly valuable for investigating bacterial resistance pathways and exploring novel antimicrobial strategies. Research applications include studying minimum inhibitory concentrations, biofilm formation effects, and synergistic interactions with other pharmaceutical compounds. The compound demonstrates broad-spectrum activity against both Gram-positive and Gram-negative bacteria, making it suitable for comprehensive microbiological investigations. Studies frequently examine its penetration characteristics, protein binding properties, and metabolic pathways in various biological matrices.

Analytical Specifications

Levoquin 250mg Technical Data
Active Ingredient Levofloxacin
Strength 250mg
Manufacturer Cipla
Form Tablet
CAS Number 100986-85-4
Molecular Formula C₁₈H₂₀FN₃O₄
Molecular Weight 361.37 g/mol
Storage Room temperature, dry conditions

Researchers utilise this formulation in antibiotic studies requiring pharmaceutical-grade levofloxacin with consistent potency and purity profiles.

Laboratory Research Compliance

This product is manufactured for laboratory research purposes exclusively and must not be used for human consumption, veterinary applications, or any therapeutic purposes. Research institutions should maintain proper documentation, storage protocols, and disposal procedures in accordance with laboratory safety regulations. All investigations must comply with institutional review board guidelines and appropriate research ethics frameworks.

Related